CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Current assets
Cash and cash equivalents	$ 52,726,305	$ 106,891,503
Restricted cash	3,537,470	0
Investment in marketable securities	1,149,828	1,127,102
Receivables, net	16,707,314	7,127,217
Receivables, net – related parties	64,057,647	49,328,739
Other receivables	12,900,211	1,003,133
Prepaid expenses and other current assets	10,121,935	7,385,098
Loan receivable – related parties	6,425,000	0
Total current assets	167,625,710	172,862,792
Noncurrent assets
Land, property and equipment, net	12,101,373	12,721,082
Intangible assets, net	109,069,858	86,875,883
Goodwill	209,313,824	185,805,880
Loans receivable – related parties	17,500,000	17,500,000
Investment in other entities – equity method	35,903,041	34,876,980
Investment in a privately held entity that does not report net asset value per share	405,000	405,000
Restricted cash	740,212	745,470
Right-of-use assets	14,319,371	0
Other assets	1,351,576	1,205,962
Total noncurrent assets	400,704,255	340,136,257
Total assets	568,329,965	512,999,049
Current liabilities
Accounts payable and accrued expenses	30,658,273	25,075,489
Fiduciary accounts payable	1,798,807	1,538,598
Medical liabilities	42,942,898	33,641,701
Income taxes payable	0	11,621,861
Bank loan	0	40,257
Finance lease obligation	101,741	101,741
Lease liabilities	2,836,010	0
Total current liabilities	78,337,729	72,019,647
Noncurrent liabilities
Lines of credit – related party	44,600,000	13,000,000
Deferred tax liability	26,651,678	19,615,935
Liability for unissued equity shares	1,185,025	1,185,025
Finance lease obligation	466,771	517,261
Lease liabilities	11,416,750	0
Total noncurrent liabilities	84,320,224	34,318,221
Total liabilities	162,657,953	106,337,868
Commitments and Contingencies (Note 10)
Mezzanine equity
Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation (“APC”)	219,582,512	225,117,029
Stockholders’ equity
Common stock, par value $0.001; 100,000,000 shares authorized, 34,638,812 and 34,578,040 shares outstanding, excluding 1,944,054 and 1,850,603 treasury shares, at June 30, 2019 and December 31, 2018, respectively	34,639	34,578
Additional paid-in capital	163,891,843	162,723,051
Retained earnings	21,473,083	17,788,203
Stockholders' equity attributable to parent	185,399,565	180,545,832
Noncontrolling interest	689,935	998,320
Total stockholders’ equity	186,089,500	181,544,152
Total liabilities, mezzanine equity and stockholders’ equity	568,329,965	512,999,049
Series A Preferred stock, par value $0.001; 5,000,000 shares authorized (inclusive of all preferred stock, including Series B Preferred stock); 1,111,111 issued and zero outstanding at June 30, 2019 and December 31, 2018, respectively
Stockholders’ equity
Preferred stock	0	0
Series B Preferred stock, par value $0.001; 5,000,000 shares authorized (inclusive of all preferred stock, including Series A Preferred stock); 555,555 issued and zero outstanding at June 30, 2019 and December 31, 2018, respectively
Stockholders’ equity
Preferred stock	$ 0	$ 0